Skip to main content

This job has expired

You will need to login before you can apply for a job.

Scientist 1 / 2, AAV Capsid Library - Gene Therapy Research

Employer
BioMarin Pharmaceutical Inc.
Location
San Rafael, California
Start date
Sep 19, 2021

View more

Job Details

POSITION DUTIES:

The Scientist will work on time-sensitive AAV capsid library projects within a large team, using knowledge of molecular biology, recombinant DNA engineering and next generation sequencing. The Scientist must have a strong background in molecular biology, restriction enzyme digestion, ligase-dependent and/or ligase-independent plasmid construction, design and the use and analysis of plasmid barcodes, nucleic acid isolation and quantification from animal tissues and cells (RNA and DNA) and NGS analysis. The Scientist must also possess experience with equipment including PCR thermocyclers, gel electrophoresis, bacterial incubators, automated DNA isolation equipment, microcentrifuges, low and high-speed centrifuges, spectrophotometric plate reader, qPCR and/or ddPCR equipment, and NGS sequencers. 

EXPERIENCE

  • Experience in AAV gene therapy
  • One year of experience as a post-doctoral fellow or research scientist in a relevant scientific discipline, including AAV capsid library generation, production, transduction and analysis
  • Ability to work effectively on team-projects. Strong collaboration & communication skills
  • Work productively on concurrent projects with strong decision-making and trouble-shooting skills (agility).
  • Design & construct bar-coded AAV capsid peptide-display library plasmids for vector library production
  • Quantitate plasmid library and vector library complexity using next-generation sequencing (amplicon-sequencing)
  • Isolate high-quality nucleic acids from primary tissues/cells (RNA/DNA) after in vivo and in vitro transduction.
  • Employ next-generation sequencing to characterization biodistribution and expression of novel capsid library variants following in vitro or in vivo screening

EDUCATION REQUIREMENTS

Ph.D degree (or foreign-equivalent) in Biology, Biochemistry, Molecular Biology, Virology, or other closely-related fields, in addition to relevant hands-on laboratory experience in AAV gene therapy.

Absent a Medical or Religious reason that prohibits vaccinations, all our incoming employees must be vaccinated

Scientific Level Differentiation:

  • Scientist 1: PhD or equivalent relevant experience, plus 0-2+ years industry experience
  • Scientist 2: PhD or equivalent relevant experience plus 2-5+ years industry experience

 We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.


 

 

 

Company

BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
Website
Location
California
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert